FDA Inspection 910188 — Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited — FEI 3004011473

The FDA completed an inspection of Intas Pharmaceuticals Limited on Dec 19, 2014 in Sanand. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 19, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sanand (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.